Detalhe da pesquisa
1.
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity.
Hematol Oncol
; 38(4): 478-486, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32542788
2.
Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi.
Hematol Oncol
; 36(1): 68-75, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28524259
3.
Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients.
Leuk Lymphoma
; 48(1): 56-64, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17325848
4.
Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study.
Leuk Lymphoma
; 56(12): 3281-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25791121
5.
Bisphosphonates-associated osteonecrosis of the jaw: A long-term follow-up of a series of 35 cases observed by GISL and evaluation of its frequency over time.
Am J Hematol
; 84(12): 850-2, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19862827